197 related articles for article (PubMed ID: 11429015)
1. The use of itraconazole as prophylaxis against invasive fungal infection in blood and marrow transplant recipients.
Boyle BM; McCann SR
Transpl Infect Dis; 2000 Jun; 2(2):72-9. PubMed ID: 11429015
[TBL] [Abstract][Full Text] [Related]
2. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
[TBL] [Abstract][Full Text] [Related]
3. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
Huang X; Chen H; Han M; Zou P; Wu D; Lai Y; Huang H; Chen X; Liu T; Zhu H; Wang J; Hu J
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole.
Glasmacher A; Hahn C; Leutner C; Molitor E; Wardelmann E; Losem C; Sauerbruch T; Marklein G; Schmidt-Wolf IG
Mycoses; 1999; 42(7-8):443-51. PubMed ID: 10546485
[TBL] [Abstract][Full Text] [Related]
5. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
[TBL] [Abstract][Full Text] [Related]
6. [Itraconazole for secondary prophylaxis of invasive fungal infection in patients undergoing chemotherapy and stem cell transplantation].
Shi JM; Wang C; Zhou YH; Yu K; Du X; Luo Y; Cai Z; He JS; Ye XJ; Zhang J; Xie WZ; Huang H
Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):413-6. PubMed ID: 23688752
[TBL] [Abstract][Full Text] [Related]
7. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation.
Sánchez-Ortega I; Patiño B; Arnan M; Peralta T; Parody R; Gudiol C; Encuentra M; Fernández de Sevilla A; Duarte RF
Bone Marrow Transplant; 2011 May; 46(5):733-9. PubMed ID: 20697369
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
[TBL] [Abstract][Full Text] [Related]
12. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.
de Vries R; Daenen S; Tolley K; Glasmacher A; Prentice A; Howells S; Christopherson H; de Jong-van den Berg LT; Postma MJ
Pharmacoeconomics; 2008; 26(1):75-90. PubMed ID: 18088160
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
15. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
16. Role of new antifungal agents in prophylaxis of mycoses in high risk patients.
van Burik JA
Curr Opin Infect Dis; 2005 Dec; 18(6):479-83. PubMed ID: 16258319
[TBL] [Abstract][Full Text] [Related]
17. Posaconazole is not superior to itraconazole for fungal prophylaxis in allogeneic blood and marrow transplantation.
Mossad SB
Bone Marrow Transplant; 2012 Oct; 47(10):1379; author reply 1380. PubMed ID: 22388277
[No Abstract] [Full Text] [Related]
18. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.
Annaloro C; Oriana A; Tagliaferri E; Bertolli V; Della Volpe A; Soligo D; Ibatici A; Pozzoli E; Lambertenghi Deliliers GL
Haematologica; 1995; 80(6):512-7. PubMed ID: 8647515
[TBL] [Abstract][Full Text] [Related]
19. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
Vardakas KZ; Michalopoulos A; Falagas ME
Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with itraconazole in systemic fungal infections.
Boogaerts M; Maertens J
Drugs; 2001; 61 Suppl 1():39-47. PubMed ID: 11219549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
